BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38588758)

  • 1. Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models.
    Dacos M; Immordino B; Diroff E; Sicard G; Kosta A; Rodallec A; Giacometti S; Ciccolini J; Fanciullino R
    Int J Pharm; 2024 May; 656():124091. PubMed ID: 38588758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer.
    Rodallec A; Brunel JM; Giacometti S; Maccario H; Correard F; Mas E; Orneto C; Savina A; Bouquet F; Lacarelle B; Ciccolini J; Fanciullino R
    Int J Nanomedicine; 2018; 13():3451-3465. PubMed ID: 29950829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer.
    Rodallec A; Sicard G; Giacometti S; Carré M; Pourroy B; Bouquet F; Savina A; Lacarelle B; Ciccolini J; Fanciullino R
    Int J Nanomedicine; 2018; 13():6677-6688. PubMed ID: 30425482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
    Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy.
    Vakili-Ghartavol R; Rezayat SM; Faridi-Majidi R; Sadri K; Jaafari MR
    Sci Rep; 2020 Mar; 10(1):5569. PubMed ID: 32221371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes.
    Vakili-Ghartavol R; Mehrabian A; Mirzavi F; Rezayat SM; Mashreghi M; Farhoudi L; Kharrazi S; Sadri K; Jaafari MR
    J Pharm Pharmacol; 2022 Sep; 74(9):1307-1319. PubMed ID: 35833585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
    Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
    J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3).
    Rodallec A; Sicard G; Giacometti S; Carre M; Maia T; Valette M; Bouquet F; Savina A; Lacarelle B; Ciccolini J; Fanciullino R
    Anticancer Drugs; 2020 Jun; 31(5):463-472. PubMed ID: 31895102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
    Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
    J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy.
    Lu X; Fang M; Yang Y; Dai Y; Xu J; Zhao D; Lu Y; Chen X; Lu S; Li N
    Drug Deliv Transl Res; 2020 Feb; 10(1):122-135. PubMed ID: 31444736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics.
    Gkionis L; Aojula H; Harris LK; Tirella A
    Int J Pharm; 2021 Jul; 604():120711. PubMed ID: 34015381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
    Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
    J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes.
    Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
    Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587
    [No Abstract]   [Full Text] [Related]  

  • 14. High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization.
    Kastner E; Kaur R; Lowry D; Moghaddam B; Wilkinson A; Perrie Y
    Int J Pharm; 2014 Dec; 477(1-2):361-8. PubMed ID: 25455778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
    Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
    Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials.
    Gdowski A; Johnson K; Shah S; Gryczynski I; Vishwanatha J; Ranjan A
    J Nanobiotechnology; 2018 Feb; 16(1):12. PubMed ID: 29433518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of in vitro antitumour activity of epirubicin in HER2+ breast cancer cells using immunoliposome formulation.
    Khaleseh F; Hemmati Azandaryani A; Fathian Kolahkaj F; Khazaei M; Derakhshandeh K
    IET Nanobiotechnol; 2021 May; 15(3):257-265. PubMed ID: 34694666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
    Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
    Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells.
    Eloy JO; Petrilli R; Brueggemeier RW; Marchetti JM; Lee RJ
    Anticancer Agents Med Chem; 2017; 17(1):48-56. PubMed ID: 27225450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method.
    Jaradat E; Weaver E; Meziane A; Lamprou DA
    Mol Pharm; 2023 Dec; 20(12):6184-6196. PubMed ID: 37931072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.